Emcure Pharmaceuticals Ltd. (EMCURE)
Market Closed
MSE MSE Primary ₹
₹
268.05B Market Cap
- P/E Ratio
0% Div Yield
- Volume
- Eps
₹
Previous Close Day Range
0 0
Year Range
0 0
Want to track EMCURE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
EMCURE is not paying dividends to its shareholders.
The last earnings report, released on Nov 11, 2025, exceeded the consensus estimates by 0.85%. On average, the company has surpassed earnings expectations by 1.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on MSE (INR).
EMCURE Chart
Similar
Emcure Pharmaceuticals Ltd. (EMCURE) FAQ
What is the stock price today?
The current price is ₹0.00.
On which exchange is it traded?
Emcure Pharmaceuticals Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is EMCURE.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 268.05B.
Has Emcure Pharmaceuticals Ltd. ever had a stock split?
No, there has never been a stock split.
Emcure Pharmaceuticals Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Satish Ramanlal Mehta CEO | MSE Exchange | INE168P01015 ISIN |
| India Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Emcure Pharmaceuticals Limited stands as a globally recognized entity, committed to the development, manufacturing, and marketing of pharmaceutical products globally. With a vast portfolio catering to a diverse range of therapeutic areas, Emcure has successfully marked its presence worldwide. Since its inception in 1981, based in Pune, India, the company has incessantly focused on expanding its reach and enhancing its product offerings, underlining its dedication to health and medical innovation.
Products and Services
Emcure Pharmaceuticals Limited provides an expansive spectrum of products and services across different therapeutic categories and technological platforms:
- Gynecology, Cardiovascular, Anti-infectives, & More: Emcure delivers a wide range of pharmaceutical products targeting diverse therapeutic areas including gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, among others. This broad spectrum ensures Emcure's capacity to address a multitude of health conditions, catering to the varied medical needs of patients worldwide.
- Vitamins, Minerals, & Nutrients: Beyond prescription medication, Emcure extends its offerings to include essential vitamins, minerals, and nutrients, underpinning the company's commitment to comprehensive healthcare and well-being.
- Complex Platforms & Technologies: The company is at the forefront of developing products using sophisticated platforms and technologies such as chiral molecules, complex APIs (Active Pharmaceutical Ingredients), photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, orals, iron products, biotherapeutics, and novel drug delivery systems. These advanced approaches underline Emcure's dedication to innovation and excellence in pharmaceutical development.
- Brand Name Products: Emcure markets its numerous and diverse pharmaceutical products under several recognized brand names such as Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo. These brands have become synonymous with quality and efficacy in their respective therapeutic fields, further establishing Emcure's reputation as a leading pharmaceutical company.
Contact Information
Address: Plot No. P-1 and P-2
Phone: 91 20 3507 0033
Website: https://www.emcure.com
